2 for Latent Tuberculosis Infection
This trial is testing how the cells within the lung react when exposed to PPD, in order to better understand tuberculosis.
- Latent Tuberculosis Infection
- Healthy Subjects
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Awards & Highlights
Find a site
Who is running the clinical trial?
Frequently Asked Questions
What other research has been conducted to evaluate the efficacy of this treatment?
"Currently, 1 clinical trial is underway to analyze the efficacy of this treatment modality and none are in their final stages. The bulk of these studies are concentrated near Bethesda, Maryland although there is one other site conducting relevant research."
Could you tell me the upper limit for participant enrollment in this clinical trial?
"Affirmative. According to the details available on clinicaltrials.gov, this experiment is looking for enrollees as of November 16th 2022 - almost 6 months after its initial posting on May 3rd 2022. The study needs a total of 100 patients from one site."
Am I able to enroll in this research endeavor?
"This clinical trial is seeking 100 healthy individuals aged 18 to 64. To qualify, patients must understand the risks and sign a consent form; they cannot have any existing medical conditions or be of reproductive age without using effective contraception methods. In addition, due to radiation exposure from bronchoscopic procedures being more dangerous for younger people, as well as elder's weakened immune responses making them less likely to respond positively to treatment, this specific age range was chosen for safety reasons."
Does this clinical experiment accept elderly participants?
"According to the criteria, participants must be between 18 and 64 years of age. For those younger than 18, there are 100 medical studies available; whereas patients older than 65 may access 507 clinical trials."
Are there opportunities for individuals to participate in this trial at the present time?
"Affirmative. Clinicaltrials.gov's information shows that this medical trial, initially posted on May 3rd 2022, is currently looking for volunteers to participate in the study. One hundred participants must be recruited from one site only."